| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |